Furthermore, the changes in SPRY2 5mC and 5hmC in adenocarcinomas observed in CRC patients from this study may have clinical implications as it pertains to identifying potential adenocarcinomas that may originate from precancerous adenomas and therefore warrants further studies. Here, SPRY2 is linked to adenocarcinoma.